| Zehra Beyza Omer, MD | |
|
360 Essex St Ste 401, Hackensack, NJ 07601-8566 | |
| (551) 996-1140 | |
| Not Available |
| Full Name | Zehra Beyza Omer |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 360 Essex St Ste 401, Hackensack, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386092153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 311262 (New York) | Secondary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 25MA11517100 (New Jersey) | Primary |
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
A team of scientists at Cold Spring Harbor Laboratory (CSHL) has determined a hierarchical set of criteria that explain how the molecular precursors of gene-regulating small RNAs are sorted by the cellular machinery.
The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.
The notice from the federal health insurance marketplace grabbed Andrew Schenker's attention: ACT NOW: YOU'RE AT RISK OF LOSING FINANCIAL ASSISTANCE STARTING JANUARY 1, 2021.
Tiens Biotech Group (USA), Inc., http://www.tiens-bio.com , today announced financial results for the year ended December 31, 2009.
› Verified 2 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Primary Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336203538 PECOS PAC ID: 7911003330 Enrollment ID: O20070502000000 |
News Archive
A team of scientists at Cold Spring Harbor Laboratory (CSHL) has determined a hierarchical set of criteria that explain how the molecular precursors of gene-regulating small RNAs are sorted by the cellular machinery.
The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.
The notice from the federal health insurance marketplace grabbed Andrew Schenker's attention: ACT NOW: YOU'RE AT RISK OF LOSING FINANCIAL ASSISTANCE STARTING JANUARY 1, 2021.
Tiens Biotech Group (USA), Inc., http://www.tiens-bio.com , today announced financial results for the year ended December 31, 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zehra Beyza Omer, MD 360 Essex St Ste 401, Hackensack, NJ 07601-8566 Ph: (551) 996-1140 | Zehra Beyza Omer, MD 360 Essex St Ste 401, Hackensack, NJ 07601-8566 Ph: (551) 996-1140 |
News Archive
A team of scientists at Cold Spring Harbor Laboratory (CSHL) has determined a hierarchical set of criteria that explain how the molecular precursors of gene-regulating small RNAs are sorted by the cellular machinery.
The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.
The notice from the federal health insurance marketplace grabbed Andrew Schenker's attention: ACT NOW: YOU'RE AT RISK OF LOSING FINANCIAL ASSISTANCE STARTING JANUARY 1, 2021.
Tiens Biotech Group (USA), Inc., http://www.tiens-bio.com , today announced financial results for the year ended December 31, 2009.
› Verified 2 days ago
Dr. Sean Shabbir Sadikot, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Dr. Noa Biran, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-8704 Fax: 551-996-0582 | |
Naresh Chanderi, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |